2. Academic Validation
  3. Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones

Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones

  • J Med Chem. 1999 Nov 18;42(23):4764-77. doi: 10.1021/jm990200p.
D Nagarathnam 1,  S W Miao,  B Lagu,  G Chiu,  J Fang,  T G Murali Dhar,  J Zhang,  S Tyagarajan,  M R Marzabadi,  F Zhang,  W C Wong,  W Sun,  D Tian,  J M Wetzel,  C Forray,  R S Chang,  T P Broten,  R W Ransom,  T W Schorn,  T B Chen,  S O'Malley,  P Kling,  K Schneck,  R Bendesky,  C M Harrell
Affiliations

Affiliation

  • 1 Departments of Chemistry and Pharmacology, Synaptic Pharmaceutical Corporation, Paramus, NJ 07652, USA.
PMID: 10579840 DOI: 10.1021/jm990200p
Abstract

Dihydropyrimidinones such as compound 12 exhibited high binding affinity and subtype selectivity for the cloned human alpha(1a) receptor. Systematic modifications of 12 led to identification of highly potent and subtype-selective compounds such as (+)-30 and (+)-103, with high binding affinity (K(i) = 0.2 nM) for alpha(1a) receptor and greater than 1500-fold selectivity over alpha(1b) and alpha(1d) adrenoceptors. The compounds were found to be functional antagonists in human, rat, and dog prostate tissues. Compound (+)-103 exhibited excellent selectively to inhibit intraurethral pressure (IUP) as compared to lowering diastolic blood pressure (DBP) in mongrel dogs (K(b)(DBP)/K(b)(IUP) = 40) suggesting uroselectivity for alpha(1a)-selective compounds.

Figures
Products